News and events
Find out the latest news and updates about the regulation of therapeutic goods in Australia, as well as events, webinars and consultations with the community.
This page is in Beta testing. We welcome your feedback and suggestions as we look to improve this page.
Industry notices and compliance undertakings
Notifications for sponsors, manufacturers, and advertisers about official decisions and new or updated regulatory requirements, as well as information about recent regulatory compliance and enforcement actions.
-
Regulatory decision notices
Access official regulatory decisions for sponsors, manufacturers and advertisers, including GMP clearances, listing notices, administrative instruments, and updates to regulatory requirements. -
Latest articles
-
Company, pharmacists issued $71k of infringement notices for alleged unlawful melatonin imports
TGA has issued 10 infringement notices totalling $71,280 to Gezond Pty Ltd and 3 registered pharmacists. -
Enforcement action disrupts illicit vape distribution network in Sydney
The TGA, working with the NSW Police Force and other state and Commonwealth enforcement agencies, supported coordinated enforcement operations targeting a company allegedly involved in the importation, storage and distribution of vaping goods, nicotine pouches, illicit tobacco and other unlawful products. -
TGA flexes its muscle against illegal peptides and steroids
TGA with the assistance of the NSW Police has seized more than $120,000 of illicit peptide and anabolic steroid products from 2 residential premises in New South Wales allegedly linked to a social media influencer.
Latest publications
-
TGA Laboratories has released a report describing our assessment of the 2026 seasonal flu vaccine
-
Communique from the 13th meeting of the Women's Health Products Working Group, 16 July 2026.
-
Advisory Committee on Medicines meeting statement
Latest consultations
-
Have your say about the content and level of detection for ethylene oxide, propylene oxide and epichlorohydrin in end use products.
-
We would like your feedback on our proposal to improve information sharing about the safety, quality and performance of medical devices.
-
We are seeking feedback on proposed changes to support automated decision making (ADM) for applications to change listed medicines.